OpenAlex
PricingAboutJobs
Log inGet started
Work

Aflibercept for Age-Related Macular Degeneration: A Game-Changer or Quiet Addition?

HTML

Year: 2012
Type: article
Source: American Journal of Ophthalmology
DOI: 10.1016/j.ajo.2012.04.020
Authors: David J. Browning, Peter K. Kaiser, Philip J. Rosenfeld, Michael W. Stewart
Institutions: Charlotte Eye Ear Nose & Throat Associates, Cleveland Clinic, Mayo Clinic in Florida
Language: English

Topic: Retinal Diseases and Treatments
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: aflibercept, age-related macular degeneration, neovascular age-related macular degeneration, anti-VEGF therapy, ranibizumab, choroidal neovascularization, pharmacokinetics, pro re nata dosing, treatment frequency, cost per patient, visual acuity outcomes
SDG: Good health and well-being

Open Access status: closed

Funders: Research to Prevent Blindness, Bayer, GlaxoSmithKline, Novartis, Alexion Pharmaceuticals, Carl Zeiss Meditec AG
OpenAlex ID: W2049825589
FWCI: 17.22
Cites: 19
Cited by: 156
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms